iRhythm Holdings, Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
iRhythm Holdings, Inc. (IRTC) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $3.03 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-06
- iRhythm Holdings, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $1.53M, a 7.52% increase year-over-year.
- iRhythm Holdings, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $1.50M, a 7.90% increase year-over-year.
- iRhythm Holdings, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $1.47M, a 12.02% increase year-over-year.
- iRhythm Holdings, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $1.45M, a 14.65% increase year-over-year.
- iRhythm Holdings, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $5.74M, a 13.33% increase from fiscal 2024.
- iRhythm Holdings, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $5.06M, a 12.66% decline from fiscal 2023.
- iRhythm Holdings, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $5.80M, a 6.58% decline from fiscal 2022.
- iRhythm Holdings, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $6.20M, a 8.12% decline from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.03M 10-Q · filed 2026-08-06 | $4.51M derived: sum of 3 quarters · filed 2026-08-06 | $5.95M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.50M 10-Q · filed 2026-04-30 | $2.98M derived: sum of 2 quarters · filed 2026-04-30 | $4.42M derived: sum of 3 quarters · filed 2026-04-30 | $5.85M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $2.92M derived: sum of 2 quarters · filed 2026-02-19 | $4.34M derived: sum of 3 quarters · filed 2026-08-06 | $5.74M 10-K · filed 2026-02-19 |
| 2025-09-30 | $1.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $2.87M derived: sum of 2 quarters · filed 2026-08-06 | $4.26M 10-Q · filed 2025-10-30 | $5.58M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.82M 10-Q · filed 2026-08-06 | $4.13M derived: sum of 3 quarters · filed 2026-08-06 | $5.39M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.39M 10-Q · filed 2026-04-30 | $2.71M derived: sum of 2 quarters · filed 2026-04-30 | $3.97M derived: sum of 3 quarters · filed 2026-04-30 | $5.21M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $2.58M derived: sum of 2 quarters · filed 2026-02-19 | $3.82M derived: sum of 3 quarters · filed 2026-02-19 | $5.06M 10-K · filed 2026-02-19 |
| 2024-09-30 | $1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $2.50M derived: sum of 2 quarters · filed 2025-10-30 | $3.75M 10-Q · filed 2025-10-30 | $5.30M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $2.48M 10-Q · filed 2025-07-31 | $4.04M derived: sum of 3 quarters · filed 2026-02-19 | $5.53M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $1.24M 10-Q · filed 2025-05-01 | $2.80M derived: sum of 2 quarters · filed 2026-02-19 | $4.29M derived: sum of 3 quarters · filed 2026-02-19 | $5.67M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $3.05M derived: sum of 2 quarters · filed 2026-02-19 | $4.43M derived: sum of 3 quarters · filed 2026-02-19 | $5.80M 10-K · filed 2026-02-19 |
| 2023-09-30 | $1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $2.88M derived: sum of 2 quarters · filed 2024-10-30 | $4.24M 10-Q · filed 2024-10-30 | $5.58M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $2.75M 10-Q · filed 2024-08-01 | $4.09M derived: sum of 3 quarters · filed 2025-02-20 | $1.09M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $1.36M 10-Q · filed 2024-05-02 | $2.70M derived: sum of 2 quarters · filed 2025-02-20 | -$294.00K derived: sum of 3 quarters · filed 2025-02-20 | $1.02M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$1.66M derived: sum of 2 quarters · filed 2025-02-20 | -$343.00K derived: sum of 3 quarters · filed 2025-02-20 | $6.20M 10-K · filed 2025-02-20 |
| 2022-09-30 | -$3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$1.68M derived: sum of 2 quarters · filed 2023-11-02 | $4.87M 10-Q · filed 2023-11-02 | $6.58M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $7.86M 10-Q · filed 2023-08-04 | $9.57M derived: sum of 3 quarters · filed 2024-02-22 | $11.39M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $6.55M 10-Q · filed 2023-05-04 | $8.26M derived: sum of 2 quarters · filed 2024-02-22 | $10.07M derived: sum of 3 quarters · filed 2024-02-22 | $11.74M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $3.52M derived: sum of 2 quarters · filed 2024-02-22 | $5.20M derived: sum of 3 quarters · filed 2024-02-22 | $6.75M 10-K · filed 2024-02-22 |
| 2021-09-30 | $1.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $3.49M derived: sum of 2 quarters · filed 2022-11-04 | $5.04M 10-Q · filed 2022-11-04 | |
| 2021-06-30 | $1.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $3.23M 10-Q · filed 2022-08-05 | ||
| 2021-03-31 | $1.55M 10-Q · filed 2022-05-06 | |||
| 2020-12-31 | $6.03M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |